Clinical Evaluation News Today

Appointment brings extensive experience in global pharma leadership and progressing ophthalmology drugs to market and further strengthens Board Exonate Ltd., a biotechnology company developing novel

Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced the expansion of its Board with the appointment of Dr Rafiq Hasan as Non-Executive Director. Rafiq brings extensive expertise in ophthalmology, specifically within the diabetic eye disease sector, from his years in global pharmaceutical businesses.

Confused by your pain? It might be coming from somewhere else! Referred pain travels along nerve pathways, causing pain in unexpected areas. Learn what pain in your arm, chest, or abdomen could mean. Dr. Reddy debunks myths and explains how doctors diagnose the true source of your pain.

This week's Targeted Pulse focuses on the latest in cervical cancer, the FDA ODAC's vote for cilta-cel, and more.

/PRNewswire/ -- The "Medical Device Software: Complying with the EU MDR, EU IVDR & FDA Regulations" conference has been added to ResearchAndMarkets.coms...

CORRECTION BY SOURCE: Corporate Update on Clinical Evaluation of MedMiras ...

Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The

MedTech Mitra is not a portal, but a whole system of expert help, facilitation, technical support and regulatory guidance.

Two chemistries in naturals can pose allergic potential under certain conditions: psoralens and terpenes. Examples of such are given through the popular ingredients bakuchiol and citrus peels or juice. Regulations and risk mitigation are also addressed.

Migraines and ADHD are comorbid. What causes headache symptoms to spike? What research shows, and how clinicians should approach treatment.